Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.19 USD | -0.98% | +5.71% | +188.51% |
04-04 | Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing | MT |
04-04 | Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+188.51% | 2.53B | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-14.14% | 31.67B | |
+51.20% | 24.62B | |
-14.56% | 15.65B | |
-13.97% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Chardan Research Initiates Coverage on Avidity Biosciences With Buy Rating, $29 Price Target